Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

NCT05350007 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-06-22

No results posted yet for this study

Summary

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Conditions

Sponsors & Collaborators

  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    lead OTHER

Principal Investigators

  • Elif Yıldırım Ayaz, M.D. · Sultan Abdülhamid Training And Research Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350007 on ClinicalTrials.gov